Scopus BioPharma, Inc. financial statements
Scopus BioPharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2022
| Revenue | USD 0 | EODHD |
| Net income | −USD 11.61M | EODHD |
| Cash and equivalents | USD 124.58K | EODHD |
Scopus BioPharma, Inc. financials on 6ix · Scopus BioPharma, Inc. on 6ix